Othera Pharmaceuticals Alternatives & Competitors

12 companies similar to Othera Pharmaceuticals

Kinarus Therapeutics

Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...

5 Post-IPO Equity $36.55M

Basel, Switzerland

Biopharma Biotechnology +2

Beacon Therapeutics

Transforming Vision, Transforming Lives

95 Series C $341.00M

London, United Kingdom

Biotechnology Health Care +1

Acuity Pharmaceuticals

Advancing Ophthalmic Health with Pioneering Solutions

Series B $19.00M

Health Care Pharmaceutical

Alkeus Pharmaceuticals, Inc.

Transformation in Sight

58 Series B $150.10M

Biotechnology Medical Devices +1

Track all Othera Pharmaceuticals competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Inflammx Therapeutics, Inc.

Modulation of Inflammasome mediated Autoinflammation - in Ophthalmology, Nephropathy and...

3 Venture round $78.59M

Tampa, United States

Biotechnology Health Care +2

BBB Therapeutics

Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-...

21 $21.00M

Leiden, The Netherlands

Biopharma Biotechnology +1

Compare

AGTC

Visionary science for life-changing cures.

117 Post-IPO Equity $195.05M

Alachua, United States

Biotechnology Health Care +1

OliX Pharmaceuticals, Inc.

Contributing to the Health and Happiness of Mankind with RNAi Technology

38 Post-IPO Equity $41.50B

Korea South

Biotechnology Pharmaceutical

Atom Therapeutics

Atom Therapeutics Co., Ltd

4 Series D $678.08M

Suzhou, China

Biotechnology Health Care

Alphyn Biologics, Inc.

Alphyn develops first-in-class, multi-target therapeutics for atopic dermatitis & other se...

4 Venture round $11.83M

United States

Health Care Health and Wellness +2

Quince Therapeutics

Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...

25 Post-IPO Equity

South San Francisco, Unit...

Biotechnology Health Care +1

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology (Nasdaq: LIXT)

6 Post-IPO Equity $10.48M

United States

Biotechnology Health Care +1

About Othera Pharmaceuticals

Othera Pharmaceuticals, founded in 2002, is a pharmaceutical company focused on advancing innovative therapeutics for age-related diseases of the eye. The company's flagship product, OT-551, is currently undergoing Phase II clinical trials for the dry form of macular degeneration (AMD). Notably, the company has reveale...

Business keywords

Ophthalmic Diseases, Pharmaceutical Company, Dry AMD, Biopharmaceuticals, Drug Development, Clinical Trials, Neuroprotectant, Glaucoma Treatment, Ophthalmology, OT-551, OT-730, OT-440

Frequently Asked Questions

Companies similar to Othera Pharmaceuticals include Kinarus Therapeutics, Beacon Therapeutics, Acuity Pharmaceuticals, Alkeus Pharmaceuticals, Inc., Inflammx Therapeutics, Inc.. They work in Biotechnology and Health Care and share Othera Pharmaceuticals's focus on drug development, clinical trials and biopharmaceuticals.

Bounce Watch lists 12 companies that share Othera Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Othera Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Othera Pharmaceuticals Profile Kinarus Therapeutics Alternatives Beacon Therapeutics Alternatives Alkeus Pharmaceuticals, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Othera Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 19 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.